My Gift to all of you - ZLAB is a stock you should consider buying now

[Luckyone]

ZLAB - A stock that you all should consider buying​

ZLAB is a Chinese Bio-Pharma company that traded as high as 193.54 (4 years ago) and is now trading at 34.00 (with a low made 16 months ago at 13.48.

The stock went down because the company being a Bio-Pharma company developing new medicines, was always in the red (re earnings and expenses). Nonetheless, during this time, the company has been successful in developing new medicines that in some cases have now been designated by China as "innovative" and likely to become established as needed medicines for things like Cancer, when all phases have shown success.

Some 2 years ago (when the stock got down to the lows), it was because the company required additional funds for generating sales of its products. That is now mostly over as some of its medicines are now starting to be used.

This BioPharma company has a market capitalization of $4.07 billion dollars, meaning that it is the 23rd largest Biopharma company in China.

Here is an AI generated future outlook for the company:

ZLAB has a positive future outlook with analysts projecting strong revenue growth and potential profitability within the next few years. Analysts are optimistic about the company's growth prospects, citing its expanding commercial portfolio, strong pipeline, and strategic focus o both the Chinese and global markets.

Citi has a buy rating on the company with a 12-month price target of $66

Chart-wise, since the low was made back in April 2024, the chart shows a clear up channel with 4 weekly closing points showing the bottom of the channel being presently at 33.22. The top of the channel has 2 points on it, and it shows the top of the channel presently being around the $50, a level that should be reached within the next 2-4 months.

The stock is presently oversold, meaning it is ready to buy now.

A weekly close below 32.73 would break the bottom of the channel, meaning that a purchase around here would offer a risk of approximately $125, versus a profit potential of $3200 (per 100 shares).

In my opinion, this is a BUY here and now.

Good Luck to all of you.

 

[iliveonramen]

A Chinese biotech company? That's like two risky things put together to create some sort of super risk. I need to Chinese crypto biotech company to sufficiently reach maximum speculation.

 

[Luckyone]

A Chinese biotech company? That's like two risky things put together to create some sort of super risk. I need to Chinese crypto biotech company to sufficiently reach maximum speculation.

You are entitled to your opinion.

Nonetheless, I have been following and trading this stock for 2 years and I have some nice profits in it already and expect more. I have not seen the risk you mention. China is not suddenly going to shut down and the people needing medicines disappear as well. During all this tariff war, the Chinese stock market has actually gone up from 19260 to 25756 (25% in value), while our market has gone up from 36611 to 45207 (21% in value), meaning that the Chinese stocks have actually done better than American stocks.

But hey, we all have our own trading strategies, and we do need to be faithful to them. Politics is not something I use to make my pocketbook decisions. Whatever puts money in my pocket, I am open to it!

 

[bythoughts]

Isn't it odd how Trump never put any tariffs on stock investing. Only proles pay the taxes he comes up with.

 

[CaughtInThe]

I'm still way underwater on BABA

 

[Luckyone]

I'm still way underwater on BABA

I bought BABA April 2024 at 74.36 and got out December 2024 at 114.56.

I bought it again this April at 102.47 and I am still in it. BABA has been good to me.

 

[Threegoofs]

ZLAB - A stock that you all should consider buying​

ZLAB is a Chinese Bio-Pharma company that traded as high as 193.54 (4 years ago) and is now trading at 34.00 (with a low made 16 months ago at 13.48.

The stock went down because the company being a Bio-Pharma company developing new medicines, was always in the red (re earnings and expenses). Nonetheless, during this time, the company has been successful in developing new medicines that in some cases have now been designated by China as "innovative" and likely to become established as needed medicines for things like Cancer, when all phases have shown success.

Some 2 years ago (when the stock got down to the lows), it was because the company required additional funds for generating sales of its products. That is now mostly over as some of its medicines are now starting to be used.

This BioPharma company has a market capitalization of $4.07 billion dollars, meaning that it is the 23rd largest Biopharma company in China.

Here is an AI generated future outlook for the company:

ZLAB has a positive future outlook with analysts projecting strong revenue growth and potential profitability within the next few years. Analysts are optimistic about the company's growth prospects, citing its expanding commercial portfolio, strong pipeline, and strategic focus o both the Chinese and global markets.

Citi has a buy rating on the company with a 12-month price target of $66

Chart-wise, since the low was made back in April 2024, the chart shows a clear up channel with 4 weekly closing points showing the bottom of the channel being presently at 33.22. The top of the channel has 2 points on it, and it shows the top of the channel presently being around the $50, a level that should be reached within the next 2-4 months.

The stock is presently oversold, meaning it is ready to buy now.

A weekly close below 32.73 would break the bottom of the channel, meaning that a purchase around here would offer a risk of approximately $125, versus a profit potential of $3200 (per 100 shares).

In my opinion, this is a BUY here and now.

Good Luck to all of you.

Is this gift like the $PLNH one?

Having said that, I am going to offer you a "freebie" mention here. I hope you take advantage of it and make some money off of it. I am in the stock myself and will be purchasing more shares this week.

Here it is:


PLNH generated a red weekly close and closed on the low of the week, suggesting further downside below last week’s low at .78 will be seen this week.



The fundamental analysts have a 52-week price target of $2.20 and a 5-year price target of $10.

$PLNH is now $.28, down from $.78 when you told us to buy. I guess the price target was a miss.